Matt WillemsenThe Mucus Miracle: How Mucosal Vaccines Could Revolutionize COVID-19 Fight
Though no COVID-19 mucosal vaccines have been authorized in the US or Europe, the workshop concluded that research in this area could yield benefits for both COVID-19 and other diseases.
Because SARS-CoV-2 enters the body and is transmitted via the respiratory tract, a vaccine to promote a mucosal immune response in the respiratory tract could be better at blocking transmission and infection.
https://scitechdaily.com/the-mucus-miracle-how-mucosal-vaccines-could-revolutionize-covid-19-fight/ #mucus #COVIDー19 #MucosalVaccines
Though no COVID-19 mucosal vaccines have been authorized in the US or Europe, the workshop concluded that research in this area could yield benefits for both COVID-19 and other diseases.
Because SARS-CoV-2 enters the body and is transmitted via the respiratory tract, a vaccine to promote a mucosal immune response in the respiratory tract could be better at blocking transmission and infection.
https://scitechdaily.com/the-mucus-miracle-how-mucosal-vaccines-could-revolutionize-covid-19-fight/ #mucus #COVIDー19 #MucosalVaccines
The Mucus Miracle: How Mucosal Vaccines Could Revolutionize COVID-19 Fight
A virtual workshop in November 2022 highlighted the importance of developing mucosal vaccines for SARS-CoV-2 that could reduce transmission and infection. Participants discussed challenges and priorities, such as identifying protection correlates, improving animal models, and determining delivery me